Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 83 | 81 | 67 | 67 | 227 |
| Accounts receivable | -288 | -148 | 108 | 20 | 96 |
| Other Working Capital | -399 | -296 | 1,492 | -96 | 192 |
| Other Operating Activity | -3,333 | -3,275 | -3,237 | -1,831 | -2,156 |
| Operating Cash Flow | $-3,937 | $-3,638 | $-1,570 | $-1,840 | $-1,640 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -65 | -20 | 2 | -122 |
| Other Investing Activity | 0 | 0 | 435 | -2 | 23 |
| Investing Cash Flow | $-15 | $-65 | $414 | $0 | $-99 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -24 | -30 | N/A | N/A | N/A |
| Common Stock Issued | 55,393 | 3,363 | -33 | -40 | 43 |
| Other Financing Activity | -1 | 5 | -18 | -68 | -32 |
| Financing Cash Flow | $55,368 | $3,338 | $-51 | $-108 | $11 |
| Beginning Cash Position | 20,273 | 20,638 | 24,866 | 28,158 | 28,827 |
| End Cash Position | 72,138 | 20,273 | 22,539 | 24,866 | 28,158 |
| Net Cash Flow | $51,416 | $-365 | $-1,207 | $-1,949 | $-1,728 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,937 | -3,638 | -1,570 | -1,840 | -1,640 |
| Capital Expenditure | -15 | -65 | -20 | N/A | -122 |
| Free Cash Flow | -3,952 | -3,703 | -1,590 | -1,840 | -1,762 |